PA Attorney General Linda Kelly announced in a press release Monday that $2.7 million is being given to the Department of Aging's PACE program.
The money will be used to help uninsured Pennsylvanians pay for their prescription drugs.
The money comes from a settlement of a lawsuit against GlaxoSmithKline. Glaxo was accused of endangering in false and misleading drug pricing practices.
The money was awarded to Pennsylvania by the U.S. District Court for the District of Massachusetts.
Kelly says the money will be targeted to help the working poor, because they are the ones who most often fall in a so-called “gap” in drug coverage. In many cases they are given little or no help to pay for their prescription drugs because they make too much money to qualify for Medicaid or other programs.
Glaxo is one of 13 drug companies accused of falsely setting average wholesale prices for their drugs. Glaxo settled the case in 2007, and reimbursement of consumers began in 2008. The $2.7 million represents Pennsylvania’s share of the money that remained after all other claims had been satisfied.
Kelly stresses that there is help available to you if can’t afford to pay for the medicines you need. To see if you qualify, please dial 1-800-955-0989. Those who qualify will pay $0 for generic medications, and $15 for name brand drugs.
The other states joining Pennsylvania in the Glaxo settlement are Arizona, Connecticut, Montana and Nevada.
The money will be used to help uninsured Pennsylvanians pay for their prescription drugs.
The money comes from a settlement of a lawsuit against GlaxoSmithKline. Glaxo was accused of endangering in false and misleading drug pricing practices.
The money was awarded to Pennsylvania by the U.S. District Court for the District of Massachusetts.
Kelly says the money will be targeted to help the working poor, because they are the ones who most often fall in a so-called “gap” in drug coverage. In many cases they are given little or no help to pay for their prescription drugs because they make too much money to qualify for Medicaid or other programs.
Glaxo is one of 13 drug companies accused of falsely setting average wholesale prices for their drugs. Glaxo settled the case in 2007, and reimbursement of consumers began in 2008. The $2.7 million represents Pennsylvania’s share of the money that remained after all other claims had been satisfied.
Kelly stresses that there is help available to you if can’t afford to pay for the medicines you need. To see if you qualify, please dial 1-800-955-0989. Those who qualify will pay $0 for generic medications, and $15 for name brand drugs.
The other states joining Pennsylvania in the Glaxo settlement are Arizona, Connecticut, Montana and Nevada.